AS

Anand Shriniwas Acharya

Active Director Director DIN 00460057
DIN 00460057 First appointment Jan 1988 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jan 1988
Shareholding value •••• Premium profile

About Anand Shriniwas Acharya

Data last updated:

Anand Shriniwas Acharya is a Director at Dr.Acharya Laboratories Private Limited (since 2005), Director at Shirdi Chemicals Private Limited (since 2000) and Director at Asvik Pharma And Chemicals Private Limited (since 1999), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Pharma and Research & Development. The 3 current companies with reported revenue have a combined latest revenue of ₹148 Cr; the largest is Dr.Acharya Laboratories Private Limited at ₹132 Cr (FY 2025). Earlier, Anand Shriniwas Acharya was a Director at Dombivli Common Effluent Treatment Plant (2009–2016).

DIN 00460057
Primary Designation Director
Industry Chemicals and Materials
First Appointment 12 Jan 1988
Oldest Company Age 38 yrs
Largest company Dr.Acharya Laboratories Private Limited · ₹132 Cr (FY 2025)
Combined revenue ₹148 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20052005₹132 Cr (FY 2025)Active
Shirdi Chemicals Private Limited U24119MH1990PTC058820
Director01 Dec 20001990₹13.87 Cr (FY 2025)Active
Director01 Sep 19991996₹2.43 Cr (FY 2025)Active
Director12 Jan 19881988Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20091994₹3.23 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shirdi Chemicals Private Limited
Dr.Acharya Laboratories Private Limited
Asvik Pharma And Chemicals Private Limited
Acharya Research Centre Private Limited
Premium access

Shareholding and investment profile for Anand Shriniwas Acharya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Shriniwas Acharya

Anand Shriniwas Acharya currently holds 4 directorships: Dr.Acharya Laboratories Private Limited (Director, since 17 May 2005, revenue ₹132 Cr (FY 2025)); Shirdi Chemicals Private Limited (Director, since 01 Dec 2000, revenue ₹13.87 Cr (FY 2025)); Asvik Pharma And Chemicals Private Limited (Director, since 01 Sep 1999, revenue ₹2.43 Cr (FY 2025)); Acharya Research Centre Private Limited (Director, since 12 Jan 1988).

Anand Shriniwas Acharya was first appointed on 12 Jan 1988 as Director at Acharya Research Centre Private Limited. The most recent appointment on record is 20 Aug 2009 at Dombivli Common Effluent Treatment Plant.

The 3 current companies of Anand Shriniwas Acharya that report revenue have a combined latest revenue of ₹148 Cr: Dr.Acharya Laboratories Private Limited ₹132 Cr (FY 2025); Shirdi Chemicals Private Limited ₹13.87 Cr (FY 2025); Asvik Pharma And Chemicals Private Limited ₹2.43 Cr (FY 2025).

Anand Shriniwas Acharya held 1 earlier board appointment: Dombivli Common Effluent Treatment Plant (Director, 20 Aug 2009 to 20 Jan 2016).

The current boards of Anand Shriniwas Acharya's companies include Shrikant Narahari Acharya (Dr.Acharya Laboratories Private Limited), Shripati Narahari Acharya (Dr.Acharya Laboratories Private Limited), Usha Shrinivas Acharya (Dr.Acharya Laboratories Private Limited), Venkatraman Narayan Bhagwat (Dr.Acharya Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available